Unexpected tarlatamab efficacy and toxicity in atypical carcinoid and large cell neuroendocrine carcinoma, and DLL3 level as a potential biomarker. // JTO Clinical and Research Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2666364326001608?dgcid=rss_sd_all
Unexpected tarlatamab efficacy and toxicity in atypical carcinoid and large cell neuroendocrine carcinoma, and DLL3 level as a potential biomarker. JTO Clinical and Research Reports. https://www.sciencedirect.com/science/article/pii/S2666364326001608?dgcid=rss_sd_all
“Unexpected tarlatamab efficacy and toxicity in atypical carcinoid and large cell neuroendocrine carcinoma, and DLL3 level as a potential biomarker.” JTO Clinical and Research Reports.
@article{article90108,
title = {Unexpected tarlatamab efficacy and toxicity in atypical carcinoid and large cell neuroendocrine carcinoma, and DLL3 level as a potential biomarker},
journal = {JTO Clinical and Research Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2666364326001608?dgcid=rss_sd_all}
}